Malíčková K - Search Results

1

Current possibilities of diagnostics and treatment of immunological causes of female infertility.

Malíčková K, Ambrusová Z, Belvončíková S, Bergendiová K, Krátká Z, Lešťan M, Luxová Š, Novák J, Tibenská E, Vydláková J, Sedláčková L. Malíčková K, et al. Cas Lek Cesk. 2021 Winter;160(1):5-13. Cas Lek Cesk. 2021. PMID: 33823598 Review. English.

2

Circulating NK and NKT cells in the diagnosis and treatment of immunological causes of female infertility - retrospective data analysis from the tertiary clinical center.

Malíčková K, Luxová Š, Krátká Z, Sedláčková L. Malíčková K, et al. Cas Lek Cesk. 2021 Winter;160(1):27-32. Cas Lek Cesk. 2021. PMID: 33823601 English.

3

Testing for COVID-19: a few points to remember.

Krátká Z, Luxová Š, Malíčková K, Fürst T, Šimková H. Krátká Z, et al. Among authors: malickova k. Cas Lek Cesk. 2020 Spring;159(2):72-77. Cas Lek Cesk. 2020. PMID: 32434339 English.

4

Anti-SARS-CoV-2 antibody testing in IBD healthcare professionals: are we currently able to provide COVID-free IBD clinics?

Malickova K, Kratka Z, Luxova S, Bortlik M, Lukas M. Malickova K, et al. Scand J Gastroenterol. 2020 Aug;55(8):917-919. doi: 10.1080/00365521.2020.1791244. Epub 2020 Jul 14. Scand J Gastroenterol. 2020. PMID: 32663041

5

Pregnancy and newborn outcome of mothers with inflammatory bowel diseases exposed to anti-TNF-α therapy during pregnancy: three-center study.

Bortlik M, Machkova N, Duricova D, Malickova K, Hrdlicka L, Lukas M, Kohout P, Shonova O, Lukas M. Bortlik M, et al. Among authors: malickova k. Scand J Gastroenterol. 2013 Aug;48(8):951-8. doi: 10.3109/00365521.2013.812141. Epub 2013 Jul 8. Scand J Gastroenterol. 2013. PMID: 23834232

6

Discontinuation of anti-tumor necrosis factor therapy in inflammatory bowel disease patients: a prospective observation.

Bortlik M, Duricova D, Machkova N, Hruba V, Lukas M, Mitrova K, Romanko I, Bina V, Malickova K, Kolar M, Lukas M. Bortlik M, et al. Among authors: malickova k. Scand J Gastroenterol. 2016;51(2):196-202. doi: 10.3109/00365521.2015.1079924. Epub 2015 Sep 2. Scand J Gastroenterol. 2016. PMID: 26329773

7

Anticarbohydrate antibodies as markers of inflammatory bowel disease in a Central European cohort.

Malickova K, Lakatos PL, Bortlik M, Komarek V, Janatkova I, Lukas M. Malickova K, et al. Eur J Gastroenterol Hepatol. 2010 Feb;22(2):144-50. doi: 10.1097/MEG.0b013e32832f5c7e. Eur J Gastroenterol Hepatol. 2010. PMID: 19927001

8

Anti-inflammatory effect of biological treatment in patients with inflammatory bowel diseases: calprotectin and IL-6 changes do not correspond to sRAGE changes.

Malícková K, Kalousová M, Fucíková T, Bortlík M, Duricová D, Komárek V, Zima T, Janatková I, Lukás M. Malícková K, et al. Scand J Clin Lab Invest. 2010 Jul;70(4):294-9. doi: 10.3109/00365513.2010.485648. Scand J Clin Lab Invest. 2010. PMID: 20446880

9

Impact of anti-tumor necrosis factor alpha antibodies administered to pregnant women with inflammatory bowel disease on long-term outcome of exposed children.

Bortlik M, Duricova D, Machkova N, Kozeluhova J, Kohout P, Hrdlicka L, Durilova M, Mitrova K, Hradsky O, Bronsky J, Malickova K, Lukas M. Bortlik M, et al. Among authors: malickova k. Inflamm Bowel Dis. 2014 Mar;20(3):495-501. doi: 10.1097/01.MIB.0000440984.86659.4f. Inflamm Bowel Dis. 2014. PMID: 24407486

10

Phosphatidylserine-dependent anti-prothrombin antibodies (aPS/PT) in infliximab-treated patients with inflammatory bowel diseases.

Malíčková K, Ďuricová D, Bortlík M, Janatková I, Zima T, Lukáš M. Malíčková K, et al. Auto Immun Highlights. 2012 Dec 23;4(1):27-32. doi: 10.1007/s13317-012-0045-0. eCollection 2013 Apr. Auto Immun Highlights. 2012. PMID: 26000139 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

63 results

Search Page